1 |
Spoerl S, Erber R, Gerken M, Taxis J, Ludwig N, Nieberle F, Biermann N, Geppert CI, Ettl T, Hartmann A, Beckhove P, Reichert TE, Spanier G, Spoerl S. A20 as a Potential New Tool in Predicting Recurrence and Patient’s Survival in Oral Squamous Cell Carcinoma. Cancers 2023;15:675. [DOI: 10.3390/cancers15030675] [Reference Citation Analysis]
|
2 |
Liu X, Deng J, Yuan Y, Chen W, Sun W, Wang Y, Huang H, Liang B, Ming T, Wen J, Huang B, Xing D. Advances in Trop2-targeted therapy: Novel agents and opportunities beyond breast cancer. Pharmacology & Therapeutics 2022;239:108296. [DOI: 10.1016/j.pharmthera.2022.108296] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
3 |
Chen K, Kostos L, Azad AA. Future directions in systemic treatment of metastatic hormone-sensitive prostate cancer. World J Urol 2022. [PMID: 36029329 DOI: 10.1007/s00345-022-04135-8] [Reference Citation Analysis]
|